Help Wanted: FDA Recruiting New CBER Director Ahead Of Gene, Cell Therapy Wave
This article was originally published in RPM Report
Executive Summary
CBER Director Midthun is stepping down at the end of the year, just as the center is moving into an era of more hands-on work in reviewing new therapeutics.